XML 50 R32.htm IDEA: XBRL DOCUMENT v3.19.1
Segment Information (Tables)
 12 Months Ended
Dec. 31, 2018
Segment Reporting [Abstract]  
Segment Information
The following table presents results of continuing operations for each reportable segment.
 
 
Mobile
Solutions
 
Power
Solutions
 
Life
Sciences
 
Corporate
and
Consolidations
 
Total
Year Ended December 31, 2018
 
 
 
 
 
 
 
 
 
 
Net sales
 
$
335,037

 
$
189,778

 
$
248,173

 
$
(2,331
)
(a)
$
770,657

Depreciation and amortization
 
$
26,217

 
$
14,753

 
$
28,091

 
$
2,067

 
$
71,128

Goodwill impairment
 
$
73,442

 
$
109,100

 
$
—

 
$
—

 
$
182,542

Income from operations
 
$
(54,103
)
 
$
(95,115
)
 
$
19,136

 
$
(48,806
)
 
$
(178,888
)
Interest expense
 

 

 

 

 
$
(61,243
)
Other
 

 

 

 

 
$
(20,903
)
Loss from continuing operations before benefit for income taxes and share of net income from joint venture
 

 

 

 

 
$
(261,034
)
Share of net income from joint venture
 
$
(14,390
)
 
—

 
—

 
—

 
$
(14,390
)
Expenditures for long-lived assets
 
$
36,660

 
$
6,459

 
$
14,645

 
$
6,272

 
$
64,036

Total assets
 
$
356,387

 
$
297,947

 
$
802,770

 
$
44,466

(b)
$
1,501,570

Year Ended December 31, 2017
 
 
 
 
 
 
 
 
 
 
Net sales
 
$
336,852

 
$
186,602

 
$
98,329

 
$
(1,990
)
(a)
$
619,793

Depreciation and amortization
 
$
24,491

 
$
14,657

 
$
12,088

 
$
1,170

 
$
52,406

Income from operations
 
$
34,405

 
$
23,440

 
$
13,271

 
$
(38,002
)
 
$
33,114

Interest expense
 

 

 

 

 
$
(52,085
)
Other
 

 

 

 

 
$
(39,902
)
Loss from continuing operations before benefit for income taxes and share of net income from joint venture
 

 

 

 

 
$
(58,873
)
Share of net income from joint venture
 
$
5,211

 
—

 
—

 
—

 
$
5,211

Expenditures for long-lived assets
 
$
24,056

 
$
5,443

 
$
—

 
$
6,907

 
$
36,406

Total assets
 
$
428,321

 
$
385,558

 
$
353,208

 
$
307,916

(b)
$
1,475,003

Year Ended December 31, 2016
 
 
 
 
 
 
 
 
 
 
Net sales
 
$
326,138

 
$
180,330

 
$
80,057

 
$
(1,571
)
(a)
$
584,954

Depreciation and amortization
 
$
22,189

 
$
15,604

 
$
12,501

 
$
427

 
$
50,721

Income from operations
 
$
29,490

 
$
24,060

 
$
9,840

 
$
(28,611
)
 
$
34,779

Interest expense
 

 

 

 

 
$
(62,870
)
Other
 

 

 

 

 
$
(2,775
)
Loss from continuing operations before benefit for income taxes and share of net income from joint venture
 

 

 

 

 
$
(30,866
)
Share of net income from joint venture
 
$
5,938

 
—

 
—

 
—

 
$
5,938

Expenditures for long-lived assets
 
$
23,077

 
$
3,125

 
$
2,227

 
$
3,465

 
$
31,894

_______________________________
(a) Includes eliminations of intersegment transactions which occur during the ordinary course of business.
(b) Total assets in Mobile Solutions includes $20.4 million and $39.8 million as of December 31, 2018 and 2017, respectively, related to the investment in our 49% owned joint venture (Note 10).
The following table summarizes the net sales and income (loss) from operations from the Paragon Medical and NN Vandalia acquisitions in the Life Sciences group and other acquisitions in the Life Sciences and Power Solutions groups for the years ended December 31, 2018 and 2017.
 
 
Year Ended December 31,
 
 
2018
 
2017
Net sales
 
 
 
 
Paragon Medical
 
$
116,998

 
$
—

NN Vandalia
 
30,668

 
6,682

Other
 
11,968

 
—

 
 
 
 
 
Income (loss) from operations
 
 
 
 
Paragon Medical
 
$
8,086

 
$
—

NN Vandalia
 
1,532

 
(458
)
Other
 
284

 
—
Summary of Sales to External Customers and Long-Lived Tangible Assets by Geographical Region
The following table summarizes long-lived tangible assets by geographical region.
 
 
Property, Plant, and Equipment, Net
As of December 31,
 
 
2018
 
2017
United States
 
$
235,975

 
$
173,269

Europe
 
50,143

 
25,288

Asia
 
42,657

 
26,078

Mexico
 
7,647

 
7,544

S. America
 
24,606

 
27,101

All foreign countries
 
$
125,053

 
$
86,011

Total
 
$
361,028

 
$
259,280